# Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen

> **NCT01728519** · PHASE1,PHASE2 · TERMINATED · sponsor: **Anergis** · enrollment: 29 (actual)

## Conditions studied

- Allergic Rhinitis
- Allergy

## Interventions

- **DRUG:** AllerT SC
- **DRUG:** AllerT ID
- **DRUG:** Placebo SC
- **DRUG:** Placebo ID

## Key facts

- **NCT ID:** NCT01728519
- **Lead sponsor:** Anergis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2009-03
- **Final completion:** 2012-07
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Recruitment was stopped before start of the pollen season
- **Last updated:** 2012-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728519, "Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01728519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*